Acumen Pharmaceuticals, Inc. (ABOS)

NASDAQ: ABOS · IEX Real-Time Price · USD

3.84

+0.01 (0.26%)

At close: Dec 29, 2023, 4:00 PM

3.77

-0.07 (-1.82%)

After-hours: Dec 29, 2023, 7:19 PM EST

Income Statement (Annual)

Financials in millions USD. Fiscal year is January - December.

Millions USD. Fiscal year is Jan - Dec.

Year	2022	2021	2020	2019
Selling, General & Admin	12.88	7.28	1.35	0.93
Research & Development	32.36	12.31	8	8.58
Operating Expenses	45.24	19.58	9.35	9.5
Operating Income	-45.24	-19.58	-9.35	-9.5
Other Expense / Income	-2.38	81.02	-2.02	-1.6
Pretax Income	-42.86	-100.61	-7.33	-7.91
Net Income	-42.86	-100.61	-7.33	-7.91
Preferred Dividends	0	0	0	-0.22
Net Income Common	-42.86	-100.61	-7.33	-7.69
Shares Outstanding (Basic)	41	20	0	0
Shares Outstanding (Diluted)	41	20	0	0
Shares Change	102.43%	4685.58%	-2.71%	-
EPS (Basic)	-1.06	-5.02	-17.48	-17.84
EPS (Diluted)	-1.06	-5.02	-17.48	-17.84
Free Cash Flow	-35.31	-18	-7.45	-6.82
Free Cash Flow Per Share	-0.87	-0.90	-17.77	-15.83
EBITDA	-42.69	-100.6	-7.33	-7.91
Depreciation & Amortization	0.17	0	0	0
EBIT	-42.86	-100.61	-7.33	-7.91

Source: Financials are provided by Nasdaq Data Link and sourced from the audited annual (10-K) and quarterly (10-Q) reports submitted to the Securities and Exchange Commission (SEC).